日本老年射血分数降低心力衰竭患者使用RAS抑制剂和β受体阻滞剂对死亡率影响的数据表

数据集获取（Figshare）

• 源站标题：Datasheet1_Effects of renin-angiotensin system inhibitor and beta-blocker use on mortality in older patients with heart failure with reduced ejection fraction in Japan.docx
• DOI：10.3389/fcvm.2024.1377228.s001
• 发布日期：2024-05-31
• 文件数：1 个
• 文件总体积：685.76 KB
• 源站页面：https://frontiersin.figshare.com/articles/dataset/Datasheet1_Effects_of_renin-angiotensin_system_inhibitor_and_beta-blocker_use_on_mortality_in_older_patients_with_heart_failure_with_reduced_ejection_fraction_in_Japan_docx/25943875

命令行下载

curl -L -o "Datasheet1_Effects of renin-angiotensin system inhibitor and beta-blocker use on mortality in older patients with heart failure with reduced ejection .docx" "https://ndownloader.figshare.com/files/46748626"

文件清单

• Datasheet1_Effects of renin-angiotensin system inhibitor and beta-blocker use on mortality in older patients with heart failure with reduced ejection .docx（685.76 KB）

文件总体积 685.76 KB（源站 API 实测）。

数据加载示例（图像类）

from PIL import Image
import glob, os

files = (glob.glob(os.path.join(path, "**", "*.png"), recursive=True)
       + glob.glob(os.path.join(path, "**", "*.jpg"), recursive=True)
       + glob.glob(os.path.join(path, "**", "*.tif"), recursive=True))
print("图像文件数:", len(files))
img = Image.open(files[0]); print("尺寸/模式:", img.size, img.mode)

# torchvision Dataset 方式:
# from torchvision import datasets
# ds = datasets.ImageFolder(path)  # 要求 子目录=类别

目录组织与标注格式以源站说明和下载后实际文件为准。

数据说明

IntroductionGuideline-directed medical therapy with renin-angiotensin system (RAS) inhibitors and beta-blockers has improved the survival of patients with heart failure (HF) and reduced left ventricular ejection fraction (HFrEF). However, it is unclear whether RAS inhibitors and beta-blockers can be administered to older patients with HF. Therefore, this study aimed to investigate the effects of beta-blockers and RAS inhibitors on the prognosis of older patients with HFrEF.
MethodsDemographic, clinical, and pharmacological data from 1,061 patients with acute decompensated HF, enrolled in the Kochi Registry of Subjects with Acute Decompensated Heart Failure (Kochi YOSACOI study), were analyzed to assess their impact on mortality. Additionally, a machine learning approach was applied to complement the conventional statistical model for analysis. Patients with HFrEF (n = 314) were divided into the all-cause mortality within 2 years group (n = 80) and the survivor group (n = 234).
ResultsOverall, 41.1% (129/314) of the patients were aged ≥80, and 25.5% (80/314) experienced all-cause mortality within 2 years. Furthermore, 57.6% (181/314) and 79.0% (248/314) were prescribed RAS inhibitors and beta-blockers, respectively. Our analysis showed that RAS inhibitor use was associated with reduced all-cause mortality and cardiac death in patients with HFrEF of all ages (P RAS inhibitors prevented all-cause mortality and cardiac death at all ages, whereas beta-blockers had different effects depending on the patient’'s age. This study suggested that the choice of beta-blockers and RAS inhibitors is more important in older patients with HFrEF than in younger patients with the same condition.

许可

CC BY 4.0

引用

学术使用请引用 DOI 10.3389/fcvm.2024.1377228.s001（source: https://frontiersin.figshare.com/articles/dataset/Datasheet1_Effects_of_renin-angiotensin_system_inhibitor_and_beta-blocker_use_on_mortality_in_older_patients_with_heart_failure_with_reduced_ejection_fraction_in_Japan_docx/25943875）。